N-(6-Methylthieno[2,3-d]pyrimidin-4-yl)glycine, 95.0%, 250mg

5-((1,4-Diazepan-1-yl)sulfonyl)isoquinolin-1(2H)-one, 95.0%, 5mg

4-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-5-amine hydrochloride, 95.0%, 1g

1-(Bromomethyl)-2-chloro-4-methoxybenzene, 95.0%, 5g

Methylaminoacetonitrile>98.0%(GC)(T)25mL

1-BROMO-4-(2,2-DIFLUOROCYCLOPROPYL)BENZENE, 95%, 250mg

GC-Kapillarsäule ROTI®Cap-5 MS Ultra, L 60 m, Ø-Innen 0,25 mm, Filmd. 1,00 µm, 1 Stück

3-Amino-3-(2-(trifluoromethyl)phenyl)propanoic acid, 95.0%, 100mg

Tropfflaschen, LDPE, weiß, 8 ml, 25 Stück

4-(Methylsulfonyl)benzylamine, 95.0%, 10g

2-chloro-N-(5-(3-nitrophenyl)-1,2,4-thiadiazol-3-yl)acetamide, 95.0%, 250mg

5,7-Dichloro-2-methylpyrazolo[1,5-a]pyrimidine, 95.0%, 5g

8-O-tert-Butyl 3-O-methyl 4-hydroxy-8-azaspiro[4.5]decane-3,8-dicarboxylate, 97%, 100mg